293 related articles for article (PubMed ID: 29207344)
1. NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases.
Pashenkov MV; Dagil YA; Pinegin BV
Int Immunopharmacol; 2018 Jan; 54():385-400. PubMed ID: 29207344
[TBL] [Abstract][Full Text] [Related]
2. NOD1 and NOD2: signaling, host defense, and inflammatory disease.
Caruso R; Warner N; Inohara N; Núñez G
Immunity; 2014 Dec; 41(6):898-908. PubMed ID: 25526305
[TBL] [Abstract][Full Text] [Related]
3. NOD1 and NOD2 in inflammatory and infectious diseases.
Trindade BC; Chen GY
Immunol Rev; 2020 Sep; 297(1):139-161. PubMed ID: 32677123
[TBL] [Abstract][Full Text] [Related]
4. The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue.
Dagil YA; Arbatsky NP; Alkhazova BI; L'vov VL; Mazurov DV; Pashenkov MV
PLoS One; 2016; 11(8):e0160784. PubMed ID: 27513337
[TBL] [Abstract][Full Text] [Related]
5. The role of NOD1 and NOD2 in host defense against chlamydial infection.
Zou Y; Lei W; He Z; Li Z
FEMS Microbiol Lett; 2016 Sep; 363(17):. PubMed ID: 27421958
[TBL] [Abstract][Full Text] [Related]
6. Modification of the structure of peptidoglycan is a strategy to avoid detection by nucleotide-binding oligomerization domain protein 1.
Wolfert MA; Roychowdhury A; Boons GJ
Infect Immun; 2007 Feb; 75(2):706-13. PubMed ID: 17145940
[TBL] [Abstract][Full Text] [Related]
7. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
[TBL] [Abstract][Full Text] [Related]
8. NOD1 and NOD2 signalling links ER stress with inflammation.
Keestra-Gounder AM; Byndloss MX; Seyffert N; Young BM; Chávez-Arroyo A; Tsai AY; Cevallos SA; Winter MG; Pham OH; Tiffany CR; de Jong MF; Kerrinnes T; Ravindran R; Luciw PA; McSorley SJ; Bäumler AJ; Tsolis RM
Nature; 2016 Apr; 532(7599):394-7. PubMed ID: 27007849
[TBL] [Abstract][Full Text] [Related]
9. Innate Immunity: ER Stress Recruits NOD1 and NOD2 for Delivery of Inflammation.
Caruso R; Núñez G
Curr Biol; 2016 Jun; 26(12):R508-R511. PubMed ID: 27326714
[TBL] [Abstract][Full Text] [Related]
10. LipL21 lipoprotein binding to peptidoglycan enables Leptospira interrogans to escape NOD1 and NOD2 recognition.
Ratet G; Santecchia I; Fanton d'Andon M; Vernel-Pauillac F; Wheeler R; Lenormand P; Fischer F; Lechat P; Haake DA; Picardeau M; Boneca IG; Werts C
PLoS Pathog; 2017 Dec; 13(12):e1006725. PubMed ID: 29211798
[TBL] [Abstract][Full Text] [Related]
11. Lack of Both Nucleotide-Binding Oligomerization Domain-Containing Proteins 1 and 2 Primes T Cells for Activation-Induced Cell Death.
Kasimsetty SG; Shigeoka AA; Scheinok AA; Gavin AL; Ulevitch RJ; McKay DB
J Immunol; 2017 Aug; 199(3):1196-1205. PubMed ID: 28652394
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization, expression and functional analysis of NOD1, NOD2 and NLRC3 in Nile tilapia (Oreochromis niloticus).
Gao FY; Pang JC; Lu MX; Yang XL; Zhu HP; Ke XL; Liu ZG; Cao JM; Wang M
Fish Shellfish Immunol; 2018 Feb; 73():207-219. PubMed ID: 29242132
[TBL] [Abstract][Full Text] [Related]
13. NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy.
Wang D
Comput Intell Neurosci; 2022; 2022():2271788. PubMed ID: 36262606
[TBL] [Abstract][Full Text] [Related]
14. Structural models of zebrafish (Danio rerio) NOD1 and NOD2 NACHT domains suggest differential ATP binding orientations: insights from computational modeling, docking and molecular dynamics simulations.
Maharana J; Sahoo BR; Bej A; Jena I; Parida A; Sahoo JR; Dehury B; Patra MC; Martha SR; Balabantray S; Pradhan SK; Behera BK
PLoS One; 2015; 10(3):e0121415. PubMed ID: 25811192
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and validation of click-modified NOD1/2 agonists.
Bharadwaj R; Anonick MV; Jaiswal S; Mashayekh S; Brown A; Wodzanowski KA; Okuda K; Silverman N; Grimes CL
Innate Immun; 2023 Nov; 29(8):186-200. PubMed ID: 37828863
[TBL] [Abstract][Full Text] [Related]
16. NOD1 and NOD2 in inflammation, immunity and disease.
Mukherjee T; Hovingh ES; Foerster EG; Abdel-Nour M; Philpott DJ; Girardin SE
Arch Biochem Biophys; 2019 Jul; 670():69-81. PubMed ID: 30578751
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.
Jakopin Ž
J Med Chem; 2014 Aug; 57(16):6897-918. PubMed ID: 24707857
[TBL] [Abstract][Full Text] [Related]
18. Activation of NOD receptors by Neisseria gonorrhoeae modulates the innate immune response.
Mavrogiorgos N; Mekasha S; Yang Y; Kelliher MA; Ingalls RR
Innate Immun; 2014 May; 20(4):377-89. PubMed ID: 23884094
[TBL] [Abstract][Full Text] [Related]
19. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.
Bertrand MJ; Doiron K; Labbé K; Korneluk RG; Barker PA; Saleh M
Immunity; 2009 Jun; 30(6):789-801. PubMed ID: 19464198
[TBL] [Abstract][Full Text] [Related]
20. NOD1 and NOD2: Beyond Peptidoglycan Sensing.
Keestra-Gounder AM; Tsolis RM
Trends Immunol; 2017 Oct; 38(10):758-767. PubMed ID: 28823510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
